Brian Vinh Hoang, DDS, PHARMD | |
3090 Senna Dr, Matthews, NC 28105-6726 | |
(704) 847-1000 | |
Not Available |
Full Name | Brian Vinh Hoang |
---|---|
Gender | Male |
Speciality | Dentist |
Location | 3090 Senna Dr, Matthews, North Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043567019 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 22522 (North Carolina) | Secondary |
183500000X | Pharmacist | 0014285 (Oregon) | Secondary |
122300000X | Dentist | 13435 (North Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Brian Vinh Hoang, DDS, PHARMD 3090 Senna Dr, Matthews, NC 28105-6726 Ph: (704) 847-1000 | Brian Vinh Hoang, DDS, PHARMD 3090 Senna Dr, Matthews, NC 28105-6726 Ph: (704) 847-1000 |
News Archive
Scientists at The University of Nottingham are studying whether harmful bacteria found in cattle could be harnessed to protect livestock from the devastating disease bovine tuberculosis (TB).
King Pharmaceuticals®, Inc. and Pain Therapeutics®, Inc. today announced that King has resubmitted a New Drug Application for REMOXY® to the U.S. Food and Drug Administration in response to a Complete Response letter received by Pain Therapeutics in December 2008.
The use of antidepressants during pregnancy has no long term neurodevelopmental or behavioural effects on the child, however they may be associated with an increased risk of postpartum haemorrhage, suggests the findings from three studies published in BJOG: An International Journal of Obstetrics and Gynaecology (BJOG).
This article explores the development, full optimization and validation study of a highly sensitive and selective ELISA for determination of cetuximab (CET) in human plasma samples.
Advanced Cell Technology, Inc., announced today that it has entered into definitive agreements on three private placements with institutional and other accredited investors under which the Company has received definitive commitments in excess of $15 million.
› Verified 8 days ago